Related references
Note: Only part of the references are listed.Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer
Tsz-Lun Yeung et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer
Tsz-Lun Yeung et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Fibronectin synthesis, but not α-smooth muscle expression, is regulated by periostin in gingival healing through FAK/JNK signaling
Shawna S. Kim et al.
SCIENTIFIC REPORTS (2019)
ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
N. Colombo et al.
ANNALS OF ONCOLOGY (2019)
Expression of Osteoblast-Specific Factor 2 (OSF-2, Periostin) Is Associated with Drug Resistance in Ovarian Cancer Cell Lines
Karolina Sterzynska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Fibronectin in malignancy: Cancer-specific alterations, protumoral effects, and therapeutic implications
Jonathan W. Rick et al.
SEMINARS IN ONCOLOGY (2019)
Characteristics of in Vivo Model Systems for Ovarian Cancer Studies
Patrycja Tudrej et al.
DIAGNOSTICS (2019)
Characteristics of in vitro model systems for ovarian cancer studies
Patrycja Tudrej et al.
ONCOLOGY IN CLINICAL PRACTICE (2019)
Advances in ovarian cancer therapy
Alexander J. Cortez et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
Fibronectin: How Its Aberrant Expression in Tumors May Improve Therapeutic Targeting
Jennifer Peyling Wang et al.
JOURNAL OF CANCER (2017)
The multifaceted role of periostin in priming the tumor microenvironments for tumor progression
Dan Cui et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Periostin in tumor microenvironment is associated with poor prognosis and platinum resistance in epithelial ovarian carcinoma
Pi-Lin Sung et al.
ONCOTARGET (2016)
Ovarian cancer-peritoneal cell interactions promote extracellular matrix processing
C. Ricciardelli et al.
ENDOCRINE-RELATED CANCER (2016)
Unsupervised analysis reveals two molecular subgroups of serous ovarian cancer with distinct gene expression profiles and survival
Katarzyna M. Lisowska et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
Upregulation of Periostin and Reactive Stroma Is Associated with Primary Chemoresistance and Predicts Clinical Outcomes in Epithelial Ovarian Cancer
Lisa Ryner et al.
CLINICAL CANCER RESEARCH (2015)
The role of periostin in neoplastic processes
Katarzyna Ratajczak-Wielgomas et al.
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA (2015)
CSIOVDB: a microarray gene expression database of epithelial ovarian cancer subtype
Tuan Zea Tan et al.
ONCOTARGET (2015)
POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer
Beth Y. Karlan et al.
GYNECOLOGIC ONCOLOGY (2014)
Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion
Hilary A. Kenny et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Microarray-based detection and expression analysis of extracellular matrix proteins in drug-resistant ovarian cancer cell lines
Radoslaw Januchowski et al.
ONCOLOGY REPORTS (2014)
Gene expression analysis in ovarian cancer - faults and hints from DNA microarray study
Katarzyna Marta Lisowska et al.
FRONTIERS IN ONCOLOGY (2014)
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer
Tuan Zea Tan et al.
EMBO MOLECULAR MEDICINE (2013)
Phase I/II study of the tumour-targeting human monoclonal antibody-cytokine fusion protein L19-TNF in patients with advanced solid tumours
G. Spitaleri et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Lysophosphatidic acid-induced expression of periostin in stromal cells: prognoistic relevance of periostin expression in epithelial ovarian cancer
Kyung Un Choi et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Fibronectin Splice Variants: Understanding Their Multiple Roles in Health and Disease Using Engineered Mouse Models
Eric S. White et al.
IUBMB LIFE (2011)
Ligand-independent activation of c-Met by fibronectin and α5β1-integrin regulates ovarian cancer invasion and metastasis
A. K. Mitra et al.
ONCOGENE (2011)
Comprehensive Serum Profiling for the Discovery of Epithelial Ovarian Cancer Biomarkers
Ping Yip et al.
PLOS ONE (2011)
Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update
Laura Morra et al.
VIRCHOWS ARCHIV (2011)
Plasma and cellular fibronectin: distinct and independent functions during tissue repair
Wing S. To et al.
FIBROGENESIS & TISSUE REPAIR (2011)
Assembly of Fibronectin Extracellular Matrix
Purva Singh et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 26 (2010)
The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma
Manfred Johannsen et al.
EUROPEAN JOURNAL OF CANCER (2010)
TP53, BCL-2 and BAX analysis in 199 ovarian cancer patients treated with taxane-platinum regimens
Izabela Ziolkowska-Seta et al.
GYNECOLOGIC ONCOLOGY (2009)
Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case
Roberto Ronca et al.
IMMUNOBIOLOGY (2009)
TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: A non-randomized retrospective study
Jolanta Kupryjanczyk et al.
BMC CANCER (2008)
Myofibroblasts are responsible for the desmoplastic reaction surrounding human pancreatic carcinomas
TNF Yen et al.
SURGERY (2002)
Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation
A Kruzynska-Frejtag et al.
MECHANISMS OF DEVELOPMENT (2001)
Share Paper
